Astria Therapeutics
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
EBITDA | -28,803 | -24,150 | -34,199 |
EBIT | -24,193 | -19,000 | |
Net Income | -24,172 | -19,928 | -31,410 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -17,096 | -19,094 | -30,254 |
Cash | 87,212 | 172,175 | 175,693 |
Basic Shares | 56,485 | 52,294 | 36,523 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -83,030 | -51,834 | -194,976 | -37,435 |
EBIT | -67,831 | -53,503 | -30,359 | -37,435 |
Net Income | -72,891 | -50,165 | -30,173 | -37,064 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -65,941 | |||
Free Cash Flow | -68,470 | -43,624 | -30,172 | -32,518 |
Cash | 175,530 | 20,525 | 86,508 | 24,930 |
Basic Shares | 30,123 | 14,620 | 8,925 | 3,058 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.42 |
2024-06-30 | -$0.43 |
2024-03-31 | -$0.38 |
2023-12-31 | -$0.94 |
